The responsibility for the content of this file/product is with CMS and no endorsement by the AMA is intended or implied. Location. 0000172922 00000 n Current book and archives back to 2000Easy-to-read online book formatLinked to and from code details. 0000131227 00000 n descriptions may not be removed, copied, or utilized within any software, product, service, solution or derivative work Learn how to get the most out of your subscription. recommending their use. Use is limited to use in Medicare, Medicaid or other programs administered by the Centers for Medicare and Medicaid Services (CMS). 0000215301 00000 n Jul 27, 2022. hb``e`````` %PDF-1.7 % The Current Procedural Terminology (CPT ) code 96127 as maintained by American Medical Weba diagnosis of asthma who demonstrate a score 19 on the Asthma Control Test (ACT), 1.5 on the Asthma Control Questionnaire (ACQ) or 1 on the Asthma Therapy Assessment Questionnaire (ATAQ) and who had at least one follow-up ACT, ACQ, or ATAQ within the 12-month reporting period. 0000068970 00000 n without the written consent of the AHA. 0000179334 00000 n Revenue Codes are equally subject to this coverage determination. Title XVIII of the Social Security Act, 1833(e), prohibits Medicare payment for any claim lacking the necessary documentation to process the claim.42 CFR 410.32 and 410.33, indicate that diagnostic tests are payable only when ordered by the physician who is treating the beneficiary for a specific medical problem and who uses the results in such treatment.CMS Manual System, Publication 100-08, Medicare Program Integrity Manual, Chapter 3, 3.2.3.3, Third-party Additional Documentation Request.CMS Manual System, Publication 100-08 , Medicare Program Integrity Manual, Chapter 15, Enrollment, 15.5.19 - 15.5.19.7 Independent Diagnostic Testing Facilities Standards. The code description for 94728 changed per the 2020 CPT/HCPCS Annual Update. 0000002202 00000 n 4 0 obj <> endobj xref 4 48 0000000016 00000 n recipient email address(es) you enter. Modifier 25 is required to be 0000002069 00000 n The mere listing of an ICD-10-CM code alone does not justify the test if the overall context and condition of the patient do not support necessity of the test.All providers of pulmonary function tests should have on file a referral (an order, a prescription) with clinical diagnoses and requested tests. Routine and/or repetitive billing for unnecessary batteries of tests is not clinically reasonable. It is more of a questionaire CMS DISCLAIMS RESPONSIBILITY FOR ANY LIABILITY ATTRIBUTABLE TO END USER USE OF THE CPT. HW[o~_>j>9nO'HBY5F=Jc/pffH Yes No Back 0000158802 00000 n For the utilization of CPT code 94664, see the Pulmonary Function Testing codes in the Article Text section above. 96160, Under Health Behavior Assessment and Intervention Procedures. Download Asthma Control Test COPD Assessment Test (CAT) The COPD Assessment Test (CAT) is a questionnaire for people with COPD. You additionally review and document asthma history, severity, control, triggers. The AMA assumes no liability for data contained or not contained herein. have the parent complete an asthma control test. 6MDrG(nj$}c`bd`v#30{` r please help me if i am wrong. If you are experiencing any technical issues related to the search, selecting the 'OK' button to reset the search data should resolve your issues. %%EOF All rights reserved. Draft articles have document IDs that begin with "DA" (e.g., DA12345). Local Coverage Articles are a type of educational document published by the Medicare Administrative Contractors (MACs). AHA copyrighted materials including the UB‐04 codes and You are leaving the CMS MCD and are being redirected to the CMS MCD Archive that contains outdated (No Longer In Effect) Local Coverage Determinations and Articles, You are leaving the CMS MCD and are being redirected to, Billing and Coding: Pulmonary Function Testing, AMA CPT / ADA CDT / AHA NUBC Copyright Statement, The Code Description for M35.02 changed from, Sicca syndrome with lung involvement to Sjogren syndrome with lung involvement and N35.03 changed from. If this is your first visit, be sure to check out the FAQ & read the forum rules. This email will be sent from you to the All rights reserved. The document is broken into multiple sections. You must log in or register to reply here. As used herein, "you" and "your" refer to you and any organization on behalf of which you are acting. 313 0 obj <> endobj CDT is a trademark of the ADA. Question Asthma Control Test. Not Controlled at all Poorly Controlled Somewhat Controlled Well Controlled Completely Controlled Back I have had an asthma episode that required a call to 911, a visit to the emergency room, or hospitalization for my asthma in the past year. required field. Any use not authorized herein is prohibited, including by way of illustration and not by way of limitation, making copies of CPT for resale and/or license, transferring copies of CPT to any party not bound by this agreement, creating any modified or derivative work of CPT, or making any commercial use of CPT. Includes English and Spanish versions of the test. In no event shall CMS be liable for direct, indirect, special, incidental, or consequential Thanks! damages arising out of the use of such information, product, or process. An asterisk (*) indicates a 0000146215 00000 n Applicable Federal Acquisition Regulation Clauses (FARS)/Department of Defense Federal Acquisition Regulation supplement (DFARS) Restrictions Apply to Government Use. 0000140274 00000 n These codes expand on the remote physiologic monitoring codes that were created in 2020 (99453, 99454, 0000131506 00000 n 0000101585 00000 n Copyright © 2022, the American Hospital Association, Chicago, Illinois. 0 Demonstration/observation of a nebulizer (94664) is usually used once or at rare intervals as a stand-alone procedure code. The ACT Questionnaire was added in 2020 to align with the 20-21 QOF requirements and remains aligned to 21 Effective 10/01/2022 - Annual ICD-10 Updates: The following ICD-10 codes were added to Group 1, Group 2 and Group 3 of the ICD-10 Codes That Support Medical Necessity: The Code Description for M35.02 changed from Sicca syndrome with lung involvement to Sjogren syndrome with lung involvement and N35.03 changed from Sicca syndrome with myopathy to Sjogren syndrome with myopathy. The asthma control test is separately reportable with code 96160. If you are looking for a specific code, use your browser's Find function (Ctrl-F) to quickly locate the code in the article. WebCPT. Sicca syndrome with myopathy to Sjogren syndrome with myopathy. The 5 items ask the patient to rate asthma symptoms and related behaviors over the previous 4 weeks. 0000289503 00000 n The American Hospital Association ("the AHA") has not reviewed, and is not responsible for, the completeness or accuracy of any information contained in this material, nor was the AHA or any of its affiliates, involved in the preparation of this material, or the analysis of information provided in the material. WebThe Asthma Florey Questionnaire is used to help gather data that would be useful for an annual asthma review. Web99420 Administer and score an asthma control screening questionnaire, such as ACT, C-ACT, ATAQ, or ACQ Tobacco Cessation 99406 Smoking and tobacco use cessation Added ICD-10-CM codes M35.89 and deleted M35.8 in Group 1 and added J12.82 and Z86.16 to Groups 1- 3 Codes of the ICD-10 Codes that Support Medical Necessity section per 2021 first quarter I-10 updates. The Asthma Control Test (ACT) is a patient-reported measure that assesses the degree of asthma control based on asthma symptoms, use of rescue medications, and effect of asthma on daily function. You can add a 59 if you did two separate things so if all you did was administer a TB test then that is all you may bill for.. the 86580 K kumeena True Blue Messages 610 Location Bellerose, NY Best answers 0000158556 00000 n under Group 1. CPT codes, descriptions and other data only are copyright 2022 American Medical Association. End User License Agreement: If you are acting on behalf of an organization, you represent that you are authorized to act on behalf of such organization and that your acceptance of the terms of this agreement creates a legally enforceable obligation of the organization. It is recommended that people with (Note: The following example is intended to illustrate documentation Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not There are multiple ways to create a PDF of a document that you are currently viewing. 0000178978 00000 n Response to Comment (RTC) articles list issues raised by external stakeholders during the Proposed LCD comment period. The Current Procedural Terminology (CPT ) code 96160 as maintained by American How would you rate your asthma control during the past 4 weeks? This Agreement will terminate upon notice if you violate its terms. Making copies or utilizing the content of the UB‐04 Manual, including the codes and/or descriptions, for internal purposes, You can use your browser's Print function (Ctrl-P on a PC or Command-P on a Mac) to view a print preview and then select PDF as the output. Nucala is indicated for the treatment of adult patients with eosinophilic granulomatosis with polyangiitis (EGPA). See our privacy policy. The views and/or positions Instructions for enabling "JavaScript" can be found here. that coverage is not influenced by Revenue Code and the article should be assumed to apply equally to all Revenue Codes. What You Can Do to Control AsthmaHealthcare Providers. Follow NAEPP Guidelines for medical management of asthma, such as assessing asthma severity, regularly monitoring asthma control, and prescribing inhaled corticosteroid when appropriate.Payers. Emphasize key components of the NAEPP in clinical practice guidelines. Payers. Healthcare Providers. Employers. Reproduced with permission. 0000172356 00000 n You can collapse such groups by clicking on the group header to make navigation easier. 0000021114 00000 n You agree to take all necessary steps to insure that your employees and agents abide by the terms of this agreement. The medical record must document the test results and usage in treatment.American Thoracic Society and the American Lung Association and the American College of Chest Physicians have published guidelines for typical usage of pulmonary function tests which represent typical community norms.Follow up testing which is weekly or monthly is appropriate only when clinically required, such as in periods of acute exacerbation of interstitial lung disease. Applications are available at the American Dental Association web site. 0000101422 00000 n Section B - The following ICD-10-CM codes are covered for CPT code 94013, 94070, 94450, 94640, 94664, 94680, 94681, 94690, 94726, 94727, 94728 and 94729. trailer <<5D7B03B4FC9442CE94B0EBF2548DFE80>]/Prev 329659>> startxref 0 %%EOF 51 0 obj <>stream The Medicare program provides limited benefits for outpatient prescription drugs. See also 42 CFR 410.33.CMS Manual System, Publication 100-02, Medicare Benefit Policy Manual, Chapter 15, 60 and 80, indicate that the technical component of diagnostic tests are not covered as "incident-to" physician healthcare services, but under a distinct coverage category and subject to supervision levels found in the Physician Fee Schedule database. CMS believes that the Internet is To submit a comment or question to CMS, please use the Feedback/Ask a Question link available at the bottom J45: Asthma J45.2: Mild intermittent asthma J45.20: Mild intermittent asthma, uncomplicated J45.21: Mild intermittent asthma, with (acute) exacerbation J45.22: Mild intermittent asthma, with status asthmaticus J45.3: Mild persistent asthma J45.30: Mild persistent asthma, uncomplicated We include the completion and scoring of the ACT in the E/M for asthma visits. A federal government website managed and paid for by the U.S. Centers for Medicare & Medicaid Services. How much of the time did your asthma keep you from getting as much done at work, school or at home in the past 4 weeks [ACT], How often have you had shortness of breath during the past 4 weeks [ACT], How often did your asthma symptoms (wheezing, coughing, shortness of breath, chest tightness or pain) wake you up at night or earlier than usual in the morning during the past 4 weeks [ACT], How often have you used your rescue inhaler or nebulizer medication (such as albuterol) during the past 4 weeks [ACT], How would you rate your asthma control during the past 4 weeks [ACT], NPI Look-Up Tool (National Provider Identifier). Indications in the primary medical record must be available for review.All equipment and studies should meet minimum standards as outlined by the American Thoracic Society.Spirometry studies, in particular, require 3 attempts to be clinically acceptable.All studies require an interpretation with a written report. of every MCD page. 96127, Under Developmental and Behavioral Screening and Testing. We NEVER sell or give your information to anyone. An official website of the United States government. CMS and its products and services are not endorsed by the AHA or any of its affiliates. Diffusion Capacity - CPT codes for diffusion capacity include 94729. %PDF-1.5 % This is illustrated by the creation of five new CPT codes (98975, 98976, 98977, 98980, 98981) to report therapeutic remote monitoring, an increasingly important avenue of patient care especially during the COVID-19 pandemic. WebPulmonary Function Testing codes: CPT codes relative to Medicares standards of reasonable and necessary care are: 94070, 94200, 94640, 94726, 94727 and 94729. 0000131340 00000 n When your asthma is well-controlled, you experience very few symptoms throughout the day and night and you can perform daily activities without shortness of breath, chest tightness, coughing or wheezing. 0000002974 00000 n Sometimes, a large group can make scrolling thru a document unwieldy. apply equally to all claims. ordering physician) when needed to evaluate the medical necessity of the service and may consider care prior to or subsequent to the service in question. See https://loinc.org/license for the full LOINC copyright and license. CPT is a trademark of the American Medical Association (AMA). You acknowledge that the ADA holds all copyright, trademark and other rights in CDT. Contractors may specify Revenue Codes to help providers identify those Revenue Codes typically used to report this service. Categorizing asthma symptoms (Control_1) Categorizing Asthma Control Test (ACT) Type of questionnaire-description: A patient self-administred tool for identifying those with poorly controlled asthma. Number of items: 5 items, with 4-week recall (on symptoms and daily functioning) Number of domains & categories 0000215264 00000 n The AMA does not directly or indirectly practice medicine or dispense medical services. The license granted herein is expressly conditioned upon your acceptance of all terms and conditions contained in this agreement. ICD-10-CM Codes that Support Medical Necessity, ICD-10-CM Codes that DO NOT Support Medical Necessity, Tuberculosis of intrathoracic lymph nodes, Tuberculosis of larynx, trachea and bronchus, Acute miliary tuberculosis of a single specified site, Acute miliary tuberculosis of multiple sites, Malignant neoplasm of right main bronchus, Malignant neoplasm of upper lobe, right bronchus or lung, Malignant neoplasm of upper lobe, left bronchus or lung, Malignant neoplasm of middle lobe, bronchus or lung, Malignant neoplasm of lower lobe, right bronchus or lung, Malignant neoplasm of lower lobe, left bronchus or lung, Malignant neoplasm of overlapping sites of right bronchus and lung, Malignant neoplasm of overlapping sites of left bronchus and lung, Malignant neoplasm of anterior mediastinum, Malignant neoplasm of posterior mediastinum, Malignant neoplasm of overlapping sites of heart, mediastinum and pleura, Secondary malignant neoplasm of right lung, Secondary malignant neoplasm of left lung, Secondary malignant neoplasm of mediastinum, Secondary malignant neoplasm of other respiratory organs, Multifocal and unisystemic Langerhans-cell histiocytosis, Carcinoma in situ of right bronchus and lung, Carcinoma in situ of left bronchus and lung, Carcinoma in situ of other parts of respiratory system, Benign neoplasm of right bronchus and lung, Benign neoplasm of left bronchus and lung, Benign neoplasm of mesothelial tissue of pleura, Neoplasm of uncertain behavior of stomach, Neoplasm of uncertain behavior of small intestine, Neoplasm of uncertain behavior of appendix, Neoplasm of uncertain behavior of trachea, bronchus and lung, Neoplasm of uncertain behavior of mediastinum, Neoplasm of uncertain behavior of other respiratory organs, Sickle-cell thalassemia beta zero with acute chest syndrome, Sickle-cell thalassemia beta plus with acute chest syndrome, Sarcoidosis of lung with sarcoidosis of lymph nodes, Multiple cranial nerve palsies in sarcoidosis, Cystic fibrosis with pulmonary manifestations, Cystic fibrosis with other intestinal manifestations, Cystic fibrosis with other manifestations, Myasthenia gravis without (acute) exacerbation, Myasthenia gravis with (acute) exacerbation, Other inflammatory and immune myopathies, not elsewhere classified, Saddle embolus of pulmonary artery with acute cor pulmonale, Other pulmonary embolism with acute cor pulmonale, Saddle embolus of pulmonary artery without acute cor pulmonale, Single subsegmental pulmonary embolism without acute cor pulmonale, Multiple subsegmental pulmonary emboli without acute cor pulmonale, Other pulmonary embolism without acute cor pulmonale, Secondary pulmonary arterial hypertension, Pulmonary hypertension due to left heart disease, Pulmonary hypertension due to lung diseases and hypoxia, Chronic thromboembolic pulmonary hypertension, Acute systolic (congestive) heart failure, Chronic systolic (congestive) heart failure, Acute on chronic systolic (congestive) heart failure, Acute diastolic (congestive) heart failure, Chronic diastolic (congestive) heart failure, Acute on chronic diastolic (congestive) heart failure, Acute combined systolic (congestive) and diastolic (congestive) heart failure, Chronic combined systolic (congestive) and diastolic (congestive) heart failure, Acute on chronic combined systolic (congestive) and diastolic (congestive) heart failure, Attention and concentration deficit following nontraumatic subarachnoid hemorrhage, Memory deficit following nontraumatic subarachnoid hemorrhage, Visuospatial deficit and spatial neglect following nontraumatic subarachnoid hemorrhage, Psychomotor deficit following nontraumatic subarachnoid hemorrhage, Frontal lobe and executive function deficit following nontraumatic subarachnoid hemorrhage, Cognitive social or emotional deficit following nontraumatic subarachnoid hemorrhage, Other symptoms and signs involving cognitive functions following nontraumatic subarachnoid hemorrhage, Hemiplegia and hemiparesis following nontraumatic subarachnoid hemorrhage affecting right dominant side, Hemiplegia and hemiparesis following nontraumatic subarachnoid hemorrhage affecting left dominant side, Hemiplegia and hemiparesis following nontraumatic subarachnoid hemorrhage affecting right non-dominant side, Hemiplegia and hemiparesis following nontraumatic subarachnoid hemorrhage affecting left non-dominant side, Other paralytic syndrome following nontraumatic subarachnoid hemorrhage affecting right dominant side, Other paralytic syndrome following nontraumatic subarachnoid hemorrhage affecting left dominant side, Other paralytic syndrome following nontraumatic subarachnoid hemorrhage affecting right non-dominant side, Other paralytic syndrome following nontraumatic subarachnoid hemorrhage affecting left non-dominant side, Other paralytic syndrome following nontraumatic subarachnoid hemorrhage, bilateral, Apraxia following nontraumatic subarachnoid hemorrhage, Dysphagia following nontraumatic subarachnoid hemorrhage, Facial weakness following nontraumatic subarachnoid hemorrhage, Ataxia following nontraumatic subarachnoid hemorrhage, Other sequelae following nontraumatic subarachnoid hemorrhage, Attention and concentration deficit following nontraumatic intracerebral hemorrhage, Memory deficit following nontraumatic intracerebral hemorrhage, Visuospatial deficit and spatial neglect following nontraumatic intracerebral hemorrhage, Psychomotor deficit following nontraumatic intracerebral hemorrhage, Frontal lobe and executive function deficit following nontraumatic intracerebral hemorrhage, Cognitive social or emotional deficit following nontraumatic intracerebral hemorrhage, Other symptoms and signs involving cognitive functions following nontraumatic intracerebral hemorrhage, Hemiplegia and hemiparesis following nontraumatic intracerebral hemorrhage affecting right dominant side, Hemiplegia and hemiparesis following nontraumatic intracerebral hemorrhage affecting left dominant side, Hemiplegia and hemiparesis following nontraumatic intracerebral hemorrhage affecting right non-dominant side, Hemiplegia and hemiparesis following nontraumatic intracerebral hemorrhage affecting left non-dominant side, Other paralytic syndrome following nontraumatic intracerebral hemorrhage affecting right dominant side, Other paralytic syndrome following nontraumatic intracerebral hemorrhage affecting left dominant side, Other paralytic syndrome following nontraumatic intracerebral hemorrhage affecting right non-dominant side, Other paralytic syndrome following nontraumatic intracerebral hemorrhage affecting left non-dominant side, Other paralytic syndrome following nontraumatic intracerebral hemorrhage, bilateral, Apraxia following nontraumatic intracerebral hemorrhage, Dysphagia following nontraumatic intracerebral hemorrhage, Facial weakness following nontraumatic intracerebral hemorrhage, Ataxia following nontraumatic intracerebral hemorrhage, Other sequelae of nontraumatic intracerebral hemorrhage, Attention and concentration deficit following other nontraumatic intracranial hemorrhage, Memory deficit following other nontraumatic intracranial hemorrhage, Visuospatial deficit and spatial neglect following other nontraumatic intracranial hemorrhage, Psychomotor deficit following other nontraumatic intracranial hemorrhage, Frontal lobe and executive function deficit following other nontraumatic intracranial hemorrhage, Cognitive social or emotional deficit following other nontraumatic intracranial hemorrhage, Other symptoms and signs involving cognitive functions following other nontraumatic intracranial hemorrhage, Hemiplegia and hemiparesis following other nontraumatic intracranial hemorrhage affecting right dominant side, Hemiplegia and hemiparesis following other nontraumatic intracranial hemorrhage affecting left dominant side, Hemiplegia and hemiparesis following other nontraumatic intracranial hemorrhage affecting right non-dominant side, Hemiplegia and hemiparesis following other nontraumatic intracranial hemorrhage affecting left non-dominant side, Other paralytic syndrome following other nontraumatic intracranial hemorrhage affecting right dominant side, Other paralytic syndrome following other nontraumatic intracranial hemorrhage affecting left dominant side, Other paralytic syndrome following other nontraumatic intracranial hemorrhage affecting right non-dominant side, Other paralytic syndrome following other nontraumatic intracranial hemorrhage affecting left non-dominant side, Other paralytic syndrome following other nontraumatic intracranial hemorrhage, bilateral, Apraxia following other nontraumatic intracranial hemorrhage, Dysphagia following other nontraumatic intracranial hemorrhage, Facial weakness following other nontraumatic intracranial hemorrhage, Ataxia following other nontraumatic intracranial hemorrhage, Other sequelae of other nontraumatic intracranial hemorrhage, Attention and concentration deficit following cerebral infarction, Memory deficit following cerebral infarction, Visuospatial deficit and spatial neglect following cerebral infarction, Psychomotor deficit following cerebral infarction, Frontal lobe and executive function deficit following cerebral infarction, Cognitive social or emotional deficit following cerebral infarction, Other symptoms and signs involving cognitive functions following cerebral infarction, Hemiplegia and hemiparesis following cerebral infarction affecting right dominant side, Hemiplegia and hemiparesis following cerebral infarction affecting left dominant side, Hemiplegia and hemiparesis following cerebral infarction affecting right non-dominant side, Hemiplegia and hemiparesis following cerebral infarction affecting left non-dominant side, Other paralytic syndrome following cerebral infarction affecting right dominant side, Other paralytic syndrome following cerebral infarction affecting left dominant side, Other paralytic syndrome following cerebral infarction affecting right non-dominant side, Other paralytic syndrome following cerebral infarction affecting left non-dominant side, Other paralytic syndrome following cerebral infarction, bilateral, Facial weakness following cerebral infarction, Attention and concentration deficit following other cerebrovascular disease, Memory deficit following other cerebrovascular disease, Visuospatial deficit and spatial neglect following other cerebrovascular disease, Psychomotor deficit following other cerebrovascular disease, Frontal lobe and executive function deficit following other cerebrovascular disease, Cognitive social or emotional deficit following other cerebrovascular disease, Other symptoms and signs involving cognitive functions following other cerebrovascular disease, Hemiplegia and hemiparesis following other cerebrovascular disease affecting right dominant side, Hemiplegia and hemiparesis following other cerebrovascular disease affecting left dominant side, Hemiplegia and hemiparesis following other cerebrovascular disease affecting right non-dominant side, Hemiplegia and hemiparesis following other cerebrovascular disease affecting left non-dominant side, Other paralytic syndrome following other cerebrovascular disease affecting right dominant side, Other paralytic syndrome following other cerebrovascular disease affecting left dominant side, Other paralytic syndrome following other cerebrovascular disease affecting right non-dominant side, Other paralytic syndrome following other cerebrovascular disease affecting left non-dominant side, Other paralytic syndrome following other cerebrovascular disease, bilateral, Apraxia following other cerebrovascular disease, Dysphagia following other cerebrovascular disease, Facial weakness following other cerebrovascular disease, Ataxia following other cerebrovascular disease, Other sequelae of other cerebrovascular disease, Influenza due to identified novel influenza A virus with pneumonia, Influenza due to identified novel influenza A virus with other respiratory manifestations, Influenza due to identified novel influenza A virus with gastrointestinal manifestations, Influenza due to identified novel influenza A virus with other manifestations, Pneumonia due to coronavirus disease 2019, Pneumonia in diseases classified elsewhere, Acute bronchitis due to Mycoplasma pneumoniae, Acute bronchitis due to Hemophilus influenzae, Acute bronchitis due to parainfluenza virus, Acute bronchitis due to respiratory syncytial virus, Acute bronchitis due to other specified organisms, Acute bronchiolitis due to respiratory syncytial virus, Acute bronchiolitis due to human metapneumovirus, Acute bronchiolitis due to other specified organisms, Other specified diseases of upper respiratory tract, Bronchitis, not specified as acute or chronic, Mixed simple and mucopurulent chronic bronchitis, Unilateral pulmonary emphysema [MacLeod's syndrome], Chronic obstructive pulmonary disease with (acute) lower respiratory infection, Chronic obstructive pulmonary disease with (acute) exacerbation, Chronic obstructive pulmonary disease, unspecified, Mild intermittent asthma with (acute) exacerbation, Mild intermittent asthma with status asthmaticus, Mild persistent asthma with (acute) exacerbation, Mild persistent asthma with status asthmaticus, Moderate persistent asthma, uncomplicated, Moderate persistent asthma with (acute) exacerbation, Moderate persistent asthma with status asthmaticus, Severe persistent asthma with (acute) exacerbation, Severe persistent asthma with status asthmaticus, Unspecified asthma with (acute) exacerbation, Unspecified asthma with status asthmaticus, Bronchiectasis with acute lower respiratory infection, Pneumoconiosis due to asbestos and other mineral fibers, Pneumoconiosis due to other dust containing silica, Pneumoconiosis due to other specified inorganic dusts, Pneumoconiosis associated with tuberculosis, Airway disease due to other specific organic dusts, Hypersensitivity pneumonitis due to other organic dusts, Bronchitis and pneumonitis due to chemicals, gases, fumes and vapors, Pulmonary edema due to chemicals, gases, fumes and vapors, Upper respiratory inflammation due to chemicals, gases, fumes and vapors, not elsewhere classified, Other acute and subacute respiratory conditions due to chemicals, gases, fumes and vapors, Chronic respiratory conditions due to chemicals, gases, fumes and vapors, Other respiratory conditions due to chemicals, gases, fumes and vapors, Pneumonitis due to inhalation of food and vomit, Pneumonitis due to inhalation of oils and essences, Pneumonitis due to inhalation of other solids and liquids, Acute pulmonary manifestations due to radiation, Chronic and other pulmonary manifestations due to radiation, Acute drug-induced interstitial lung disorders, Chronic drug-induced interstitial lung disorders, Respiratory conditions due to smoke inhalation, Respiratory conditions due to other specified external agents, Other pulmonary eosinophilia, not elsewhere classified, Idiopathic interstitial pneumonia, not otherwise specified, Idiopathic non-specific interstitial pneumonitis, Respiratory bronchiolitis interstitial lung disease, Interstitial lung disease with progressive fibrotic phenotype in diseases classified elsewhere, Other interstitial pulmonary diseases with fibrosis in diseases classified elsewhere, Adult pulmonary Langerhans cell histiocytosis, Alveolar capillary dysplasia with vein misalignment, Other interstitial lung diseases of childhood, Other specified interstitial pulmonary diseases, Pleural effusion, not elsewhere classified, Pleural effusion in other conditions classified elsewhere, Acute pulmonary insufficiency following thoracic surgery, Acute pulmonary insufficiency following nonthoracic surgery, Chronic pulmonary insufficiency following surgery, Acute and chronic postprocedural respiratory failure, Acute respiratory failure with hypercapnia, Chronic respiratory failure with hypercapnia, Acute and chronic respiratory failure with hypoxia, Acute and chronic respiratory failure with hypercapnia, Other diseases of bronchus, not elsewhere classified, Respiratory disorders in diseases classified elsewhere, Rheumatoid lung disease with rheumatoid arthritis of right shoulder, Rheumatoid lung disease with rheumatoid arthritis of left shoulder, Rheumatoid lung disease with rheumatoid arthritis of right elbow, Rheumatoid lung disease with rheumatoid arthritis of left elbow, Rheumatoid lung disease with rheumatoid arthritis of right wrist, Rheumatoid lung disease with rheumatoid arthritis of left wrist, Rheumatoid lung disease with rheumatoid arthritis of right hand, Rheumatoid lung disease with rheumatoid arthritis of left hand, Rheumatoid lung disease with rheumatoid arthritis of right hip, Rheumatoid lung disease with rheumatoid arthritis of left hip, Rheumatoid lung disease with rheumatoid arthritis of right knee, Rheumatoid lung disease with rheumatoid arthritis of left knee, Rheumatoid lung disease with rheumatoid arthritis of right ankle and foot, Rheumatoid lung disease with rheumatoid arthritis of left ankle and foot, Rheumatoid lung disease with rheumatoid arthritis of multiple sites, Rheumatoid vasculitis with rheumatoid arthritis of right shoulder, Rheumatoid vasculitis with rheumatoid arthritis of left shoulder, Rheumatoid vasculitis with rheumatoid arthritis of right elbow, Rheumatoid vasculitis with rheumatoid arthritis of left elbow, Rheumatoid vasculitis with rheumatoid arthritis of right wrist, Rheumatoid vasculitis with rheumatoid arthritis of left wrist, Rheumatoid vasculitis with rheumatoid arthritis of right hand, Rheumatoid vasculitis with rheumatoid arthritis of left hand, Rheumatoid vasculitis with rheumatoid arthritis of right hip, Rheumatoid vasculitis with rheumatoid arthritis of left hip, Rheumatoid vasculitis with rheumatoid arthritis of right knee, Rheumatoid vasculitis with rheumatoid arthritis of left knee, Rheumatoid vasculitis with rheumatoid arthritis of right ankle and foot, Rheumatoid vasculitis with rheumatoid arthritis of left ankle and foot, Rheumatoid vasculitis with rheumatoid arthritis of multiple sites, Rheumatoid heart disease with rheumatoid arthritis of right shoulder, Rheumatoid heart disease with rheumatoid arthritis of left shoulder, Rheumatoid heart disease with rheumatoid arthritis of right elbow, Rheumatoid heart disease with rheumatoid arthritis of left elbow, Rheumatoid heart disease with rheumatoid arthritis of right wrist, Rheumatoid heart disease with rheumatoid arthritis of left wrist, Rheumatoid heart disease with rheumatoid arthritis of right hand, Rheumatoid heart disease with rheumatoid arthritis of left hand, Rheumatoid heart disease with rheumatoid arthritis of right hip, Rheumatoid heart disease with rheumatoid arthritis of left hip, Rheumatoid heart disease with rheumatoid arthritis of right knee, Rheumatoid heart disease with rheumatoid arthritis of left knee, Rheumatoid heart disease with rheumatoid arthritis of right ankle and foot, Rheumatoid heart disease with rheumatoid arthritis of left ankle and foot, Rheumatoid heart disease with rheumatoid arthritis of multiple sites, Rheumatoid myopathy with rheumatoid arthritis of right shoulder, Rheumatoid myopathy with rheumatoid arthritis of left shoulder, Rheumatoid myopathy with rheumatoid arthritis of right elbow, Rheumatoid myopathy with rheumatoid arthritis of left elbow, Rheumatoid myopathy with rheumatoid arthritis of right wrist, Rheumatoid myopathy with rheumatoid arthritis of left wrist, Rheumatoid myopathy with rheumatoid arthritis of right hand, Rheumatoid myopathy with rheumatoid arthritis of left hand, Rheumatoid myopathy with rheumatoid arthritis of right hip, Rheumatoid myopathy with rheumatoid arthritis of left hip, Rheumatoid myopathy with rheumatoid arthritis of right knee, Rheumatoid myopathy with rheumatoid arthritis of left knee, Rheumatoid myopathy with rheumatoid arthritis of right ankle and foot, Rheumatoid myopathy with rheumatoid arthritis of left ankle and foot, Rheumatoid myopathy with rheumatoid arthritis of multiple sites, Rheumatoid polyneuropathy with rheumatoid arthritis of right shoulder, Rheumatoid polyneuropathy with rheumatoid arthritis of left shoulder, Rheumatoid polyneuropathy with rheumatoid arthritis of right elbow, Rheumatoid polyneuropathy with rheumatoid arthritis of left elbow, Rheumatoid polyneuropathy with rheumatoid arthritis of right wrist, Rheumatoid polyneuropathy with rheumatoid arthritis of left wrist, Rheumatoid polyneuropathy with rheumatoid arthritis of right hand, Rheumatoid polyneuropathy with rheumatoid arthritis of left hand, Rheumatoid polyneuropathy with rheumatoid arthritis of right hip, Rheumatoid polyneuropathy with rheumatoid arthritis of left hip, Rheumatoid polyneuropathy with rheumatoid arthritis of right knee, Rheumatoid polyneuropathy with rheumatoid arthritis of left knee, Rheumatoid polyneuropathy with rheumatoid arthritis of right ankle and foot, Rheumatoid polyneuropathy with rheumatoid arthritis of left ankle and foot, Rheumatoid polyneuropathy with rheumatoid arthritis of multiple sites, Rheumatoid arthritis of right shoulder with involvement of other organs and systems, Rheumatoid arthritis of left shoulder with involvement of other organs and systems, Rheumatoid arthritis of right elbow with involvement of other organs and systems, Rheumatoid arthritis of left elbow with involvement of other organs and systems, Rheumatoid arthritis of right wrist with involvement of other organs and systems, Rheumatoid arthritis of left wrist with involvement of other organs and systems, Rheumatoid arthritis of right hand with involvement of other organs and systems, Rheumatoid arthritis of left hand with involvement of other organs and systems, Rheumatoid arthritis of right hip with involvement of other organs and systems, Rheumatoid arthritis of left hip with involvement of other organs and systems, Rheumatoid arthritis of right knee with involvement of other organs and systems, Rheumatoid arthritis of left knee with involvement of other organs and systems, Rheumatoid arthritis of right ankle and foot with involvement of other organs and systems, Rheumatoid arthritis of left ankle and foot with involvement of other organs and systems, Rheumatoid arthritis of multiple sites with involvement of other organs and systems, Rheumatoid arthritis without rheumatoid factor, vertebrae, Rheumatoid arthritis without rheumatoid factor, multiple sites, Juvenile rheumatoid arthritis with systemic onset, right shoulder, Juvenile rheumatoid arthritis with systemic onset, left shoulder, Juvenile rheumatoid arthritis with systemic onset, right elbow, Juvenile rheumatoid arthritis with systemic onset, left elbow, Juvenile rheumatoid arthritis with systemic onset, right wrist, Juvenile rheumatoid arthritis with systemic onset, left wrist, Juvenile rheumatoid arthritis with systemic onset, right hand, Juvenile rheumatoid arthritis with systemic onset, left hand, Juvenile rheumatoid arthritis with systemic onset, right hip, Juvenile rheumatoid arthritis with systemic onset, left hip, Juvenile rheumatoid arthritis with systemic onset, right knee, Juvenile rheumatoid arthritis with systemic onset, left knee, Juvenile rheumatoid arthritis with systemic onset, right ankle and foot, Juvenile rheumatoid arthritis with systemic onset, left ankle and foot, Juvenile rheumatoid arthritis with systemic onset, vertebrae, Juvenile rheumatoid arthritis with systemic onset, multiple sites, Juvenile rheumatoid polyarthritis (seronegative), Polyarteritis with lung involvement [Churg-Strauss], Wegener's granulomatosis without renal involvement, Wegener's granulomatosis with renal involvement, Drug-induced systemic lupus erythematosus, Endocarditis in systemic lupus erythematosus, Pericarditis in systemic lupus erythematosus, Lung involvement in systemic lupus erythematosus, Glomerular disease in systemic lupus erythematosus, Tubulo-interstitial nephropathy in systemic lupus erythematosus, Other organ or system involvement in systemic lupus erythematosus, Other forms of systemic lupus erythematosus, Juvenile dermatomyositis with respiratory involvement, Juvenile dermatomyositis with other organ involvement, Other dermatomyositis with respiratory involvement, Other dermatomyositis with other organ involvement, Polymyositis with respiratory involvement, Polymyositis with other organ involvement, Systemic sclerosis induced by drug and chemical, Other specified systemic involvement of connective tissue, Dermato(poly)myositis in neoplastic disease, Systemic disorders of connective tissue in other diseases classified elsewhere, Postural kyphosis, cervicothoracic region, Infantile idiopathic scoliosis, cervicothoracic region, Infantile idiopathic scoliosis, thoracic region, Infantile idiopathic scoliosis, thoracolumbar region, Juvenile idiopathic scoliosis, cervicothoracic region, Juvenile idiopathic scoliosis, thoracic region, Juvenile idiopathic scoliosis, thoracolumbar region, Adolescent idiopathic scoliosis, cervicothoracic region, Adolescent idiopathic scoliosis, thoracic region, Adolescent idiopathic scoliosis, thoracolumbar region, Other idiopathic scoliosis, cervicothoracic region, Other idiopathic scoliosis, thoracic region, Other idiopathic scoliosis, thoracolumbar region, Thoracogenic scoliosis, thoracolumbar region, Other infective spondylopathies, occipito-atlanto-axial region, Other infective spondylopathies, cervical region, Other infective spondylopathies, cervicothoracic region, Other infective spondylopathies, thoracic region, Other infective spondylopathies, thoracolumbar region, Other infective spondylopathies, multiple sites in spine, Other specified inflammatory spondylopathies, occipito-atlanto-axial region, Other specified inflammatory spondylopathies, cervical region, Other specified inflammatory spondylopathies, cervicothoracic region, Other specified inflammatory spondylopathies, thoracic region, Other specified inflammatory spondylopathies, thoracolumbar region, Other specified inflammatory spondylopathies, multiple sites in spine, Other biomechanical lesions of thoracic region, Other nonspecific abnormal finding of lung field, Abnormal results of pulmonary function studies, Toxic effect of chlorofluorocarbons, accidental (unintentional), initial encounter, Toxic effect of chlorofluorocarbons, accidental (unintentional), subsequent encounter, Toxic effect of chlorofluorocarbons, accidental (unintentional), sequela, Toxic effect of chlorofluorocarbons, intentional self-harm, initial encounter, Toxic effect of chlorofluorocarbons, intentional self-harm, subsequent encounter, Toxic effect of chlorofluorocarbons, intentional self-harm, sequela, Toxic effect of chlorofluorocarbons, assault, initial encounter, Toxic effect of chlorofluorocarbons, assault, subsequent encounter, Toxic effect of chlorofluorocarbons, assault, sequela, Toxic effect of chlorofluorocarbons, undetermined, initial encounter, Toxic effect of chlorofluorocarbons, undetermined, subsequent encounter, Toxic effect of chlorofluorocarbons, undetermined, sequela, Toxic effect of hydrogen cyanide, accidental (unintentional), initial encounter, Toxic effect of hydrogen cyanide, accidental (unintentional), subsequent encounter, Toxic effect of hydrogen cyanide, accidental (unintentional), sequela, Toxic effect of hydrogen cyanide, intentional self-harm, initial encounter, Toxic effect of hydrogen cyanide, intentional self-harm, subsequent encounter, Toxic effect of hydrogen cyanide, intentional self-harm, sequela, Toxic effect of hydrogen cyanide, assault, initial encounter, Toxic effect of hydrogen cyanide, assault, subsequent encounter, Toxic effect of hydrogen cyanide, assault, sequela, Toxic effect of hydrogen cyanide, undetermined, initial encounter, Toxic effect of hydrogen cyanide, undetermined, subsequent encounter, Toxic effect of hydrogen cyanide, undetermined, sequela, Toxic effect of nitrogen oxides, accidental (unintentional), initial encounter, Toxic effect of nitrogen oxides, accidental (unintentional), subsequent encounter, Toxic effect of nitrogen oxides, accidental (unintentional), sequela, Toxic effect of nitrogen oxides, intentional self-harm, initial encounter, Toxic effect of nitrogen oxides, intentional self-harm, subsequent encounter, Toxic effect of nitrogen oxides, intentional self-harm, sequela, Toxic effect of nitrogen oxides, assault, initial encounter, Toxic effect of nitrogen oxides, assault, subsequent encounter, Toxic effect of nitrogen oxides, assault, sequela, Toxic effect of nitrogen oxides, undetermined, initial encounter, Toxic effect of nitrogen oxides, undetermined, subsequent encounter, Toxic effect of nitrogen oxides, undetermined, sequela, Toxic effect of sulfur dioxide, accidental (unintentional), initial encounter, Toxic effect of sulfur dioxide, accidental (unintentional), subsequent encounter, Toxic effect of sulfur dioxide, accidental (unintentional), sequela, Toxic effect of sulfur dioxide, intentional self-harm, initial encounter, Toxic effect of sulfur dioxide, intentional self-harm, subsequent encounter, Toxic effect of sulfur dioxide, intentional self-harm, sequela, Toxic effect of sulfur dioxide, assault, initial encounter, Toxic effect of sulfur dioxide, assault, subsequent encounter, Toxic effect of sulfur dioxide, assault, sequela, Toxic effect of sulfur dioxide, undetermined, initial encounter, Toxic effect of sulfur dioxide, undetermined, subsequent encounter, Toxic effect of sulfur dioxide, undetermined, sequela, Toxic effect of formaldehyde, accidental (unintentional), initial encounter, Toxic effect of formaldehyde, accidental (unintentional), subsequent encounter, Toxic effect of formaldehyde, accidental (unintentional), sequela, Toxic effect of formaldehyde, intentional self-harm, initial encounter, Toxic effect of formaldehyde, intentional self-harm, subsequent encounter, Toxic effect of formaldehyde, intentional self-harm, sequela, Toxic effect of formaldehyde, assault, initial encounter, Toxic effect of formaldehyde, assault, subsequent encounter, Toxic effect of formaldehyde, assault, sequela, Toxic effect of formaldehyde, undetermined, initial encounter, Toxic effect of formaldehyde, undetermined, subsequent encounter, Toxic effect of formaldehyde, undetermined, sequela, Toxic effect of lacrimogenic gas, accidental (unintentional), initial encounter, Toxic effect of lacrimogenic gas, accidental (unintentional), subsequent encounter, Toxic effect of lacrimogenic gas, accidental (unintentional), sequela, Toxic effect of lacrimogenic gas, intentional self-harm, initial encounter, Toxic effect of lacrimogenic gas, intentional self-harm, subsequent encounter, Toxic effect of lacrimogenic gas, intentional self-harm, sequela, Toxic effect of lacrimogenic gas, assault, initial encounter, Toxic effect of lacrimogenic gas, assault, subsequent encounter, Toxic effect of lacrimogenic gas, assault, sequela, Toxic effect of lacrimogenic gas, undetermined, initial encounter, Toxic effect of lacrimogenic gas, undetermined, subsequent encounter, Toxic effect of lacrimogenic gas, undetermined, sequela, Toxic effect of chlorine gas, accidental (unintentional), initial encounter, Toxic effect of chlorine gas, accidental (unintentional), subsequent encounter, Toxic effect of chlorine gas, accidental (unintentional), sequela, Toxic effect of chlorine gas, intentional self-harm, initial encounter, Toxic effect of chlorine gas, intentional self-harm, subsequent encounter, Toxic effect of chlorine gas, intentional self-harm, sequela, Toxic effect of chlorine gas, assault, initial encounter, Toxic effect of chlorine gas, assault, subsequent encounter, Toxic effect of chlorine gas, assault, sequela, Toxic effect of chlorine gas, undetermined, initial encounter, Toxic effect of chlorine gas, undetermined, subsequent encounter, Toxic effect of chlorine gas, undetermined, sequela, Toxic effect of fluorine gas and hydrogen fluoride, accidental (unintentional), initial encounter, Toxic effect of fluorine gas and hydrogen fluoride, accidental (unintentional), subsequent encounter, Toxic effect of fluorine gas and hydrogen fluoride, accidental (unintentional), sequela, Toxic effect of fluorine gas and hydrogen fluoride, intentional self-harm, initial encounter, Toxic effect of fluorine gas and hydrogen fluoride, intentional self-harm, subsequent encounter, Toxic effect of fluorine gas and hydrogen fluoride, intentional self-harm, sequela, Toxic effect of fluorine gas and hydrogen fluoride, assault, initial encounter, Toxic effect of fluorine gas and hydrogen fluoride, assault, subsequent encounter, Toxic effect of fluorine gas and hydrogen fluoride, assault, sequela, Toxic effect of fluorine gas and hydrogen fluoride, undetermined, initial encounter, Toxic effect of fluorine gas and hydrogen fluoride, undetermined, subsequent encounter, Toxic effect of fluorine gas and hydrogen fluoride, undetermined, sequela, Toxic effect of hydrogen sulfide, accidental (unintentional), initial encounter, Toxic effect of hydrogen sulfide, accidental (unintentional), subsequent encounter, Toxic effect of hydrogen sulfide, accidental (unintentional), sequela, Toxic effect of hydrogen sulfide, intentional self-harm, initial encounter, Toxic effect of hydrogen sulfide, intentional self-harm, subsequent encounter, Toxic effect of hydrogen sulfide, intentional self-harm, sequela, Toxic effect of hydrogen sulfide, assault, initial encounter, Toxic effect of hydrogen sulfide, assault, subsequent encounter, Toxic effect of hydrogen sulfide, assault, sequela, Toxic effect of hydrogen sulfide, undetermined, initial encounter, Toxic effect of hydrogen sulfide, undetermined, subsequent encounter, Toxic effect of hydrogen sulfide, undetermined, sequela, Toxic effect of carbon dioxide, accidental (unintentional), initial encounter, Toxic effect of carbon dioxide, accidental (unintentional), subsequent encounter, Toxic effect of carbon dioxide, accidental (unintentional), sequela, Toxic effect of carbon dioxide, intentional self-harm, initial encounter, Toxic effect of carbon dioxide, intentional self-harm, subsequent encounter, Toxic effect of carbon dioxide, intentional self-harm, sequela, Toxic effect of carbon dioxide, assault, initial encounter, Toxic effect of carbon dioxide, assault, subsequent encounter, Toxic effect of carbon dioxide, assault, sequela, Toxic effect of carbon dioxide, undetermined, initial encounter, Toxic effect of carbon dioxide, undetermined, subsequent encounter, Toxic effect of carbon dioxide, undetermined, sequela, Toxic effect of smoke, accidental (unintentional), initial encounter, Toxic effect of smoke, accidental (unintentional), subsequent encounter, Toxic effect of smoke, accidental (unintentional), sequela, Toxic effect of smoke, intentional self-harm, initial encounter, Toxic effect of smoke, intentional self-harm, subsequent encounter, Toxic effect of smoke, intentional self-harm, sequela, Toxic effect of smoke, assault, initial encounter, Toxic effect of smoke, assault, subsequent encounter, Toxic effect of smoke, undetermined, initial encounter, Toxic effect of smoke, undetermined, subsequent encounter, Toxic effect of smoke, undetermined, sequela, Toxic effect of other specified gases, fumes and vapors, accidental (unintentional), initial encounter, Toxic effect of other specified gases, fumes and vapors, accidental (unintentional), subsequent encounter, Toxic effect of other specified gases, fumes and vapors, accidental (unintentional), sequela, Toxic effect of other specified gases, fumes and vapors, intentional self-harm, initial encounter, Toxic effect of other specified gases, fumes and vapors, intentional self-harm, subsequent encounter, Toxic effect of other specified gases, fumes and vapors, intentional self-harm, sequela, Toxic effect of other specified gases, fumes and vapors, assault, initial encounter, Toxic effect of other specified gases, fumes and vapors, assault, subsequent encounter, Toxic effect of other specified gases, fumes and vapors, assault, sequela, Toxic effect of other specified gases, fumes and vapors, undetermined, initial encounter, Toxic effect of other specified gases, fumes and vapors, undetermined, subsequent encounter, Toxic effect of other specified gases, fumes and vapors, undetermined, sequela, Toxic effect of chewing tobacco, accidental (unintentional), initial encounter, Toxic effect of chewing tobacco, accidental (unintentional), subsequent encounter, Toxic effect of chewing tobacco, accidental (unintentional), sequela, Toxic effect of chewing tobacco, intentional self-harm, initial encounter, Toxic effect of chewing tobacco, intentional self-harm, subsequent encounter, Toxic effect of chewing tobacco, intentional self-harm, sequela, Toxic effect of chewing tobacco, assault, initial encounter, Toxic effect of chewing tobacco, assault, subsequent encounter, Toxic effect of chewing tobacco, assault, sequela, Toxic effect of chewing tobacco, undetermined, initial encounter, Toxic effect of chewing tobacco, undetermined, subsequent encounter, Toxic effect of chewing tobacco, undetermined, sequela, Toxic effect of tobacco cigarettes, accidental (unintentional), initial encounter, Toxic effect of tobacco cigarettes, accidental (unintentional), subsequent encounter, Toxic effect of tobacco cigarettes, accidental (unintentional), sequela, Toxic effect of tobacco cigarettes, intentional self-harm, initial encounter, Toxic effect of tobacco cigarettes, intentional self-harm, subsequent encounter, Toxic effect of tobacco cigarettes, intentional self-harm, sequela, Toxic effect of tobacco cigarettes, assault, initial encounter, Toxic effect of tobacco cigarettes, assault, subsequent encounter, Toxic effect of tobacco cigarettes, assault, sequela, Toxic effect of tobacco cigarettes, undetermined, initial encounter, Toxic effect of tobacco cigarettes, undetermined, subsequent encounter, Toxic effect of tobacco cigarettes, undetermined, sequela, Toxic effect of other tobacco and nicotine, accidental (unintentional), initial encounter, Toxic effect of other tobacco and nicotine, accidental (unintentional), subsequent encounter, Toxic effect of other tobacco and nicotine, accidental (unintentional), sequela, Toxic effect of other tobacco and nicotine, intentional self-harm, initial encounter, Toxic effect of other tobacco and nicotine, intentional self-harm, subsequent encounter, Toxic effect of other tobacco and nicotine, intentional self-harm, sequela, Toxic effect of other tobacco and nicotine, assault, initial encounter, Toxic effect of other tobacco and nicotine, assault, subsequent encounter, Toxic effect of other tobacco and nicotine, assault, sequela, Toxic effect of other tobacco and nicotine, undetermined, initial encounter, Toxic effect of other tobacco and nicotine, undetermined, subsequent encounter, Toxic effect of other tobacco and nicotine, undetermined, sequela, Encounter for aftercare following heart transplant, Encounter for aftercare following lung transplant, Encounter for aftercare following heart-lung transplant, Personal history of latent tuberculosis infection, Personal history of pneumonia (recurrent), Personal history of other diseases of the respiratory system, Morbid (severe) obesity with alveolar hypoventilation, Some older versions have been archived. American Medical Association ( AMA ) } c ` cpt code for asthma control test ` v # 30 { ` r please me! Is a trademark of the ADA type of educational document published by the AHA or any of its.! Rights in CDT additionally review and document asthma history, severity, control,.! E.G., DA12345 ) clicking on the group header to make navigation easier published by the AMA is or! The NAEPP in clinical practice guidelines to insure that your employees and agents abide by the U.S. Centers Medicare. For Medicare & Medicaid Services no endorsement by the Medicare Administrative Contractors ( MACs.! Behavioral Screening and Testing the terms of this file/product is with CMS and its products Services. ( RTC ) articles list issues raised by external stakeholders during the LCD! Polyangiitis ( EGPA ) CMS be liable for direct, indirect,,. To use in Medicare, Medicaid or other programs administered by the Centers. This email will be sent from you to the all rights reserved intervals as a stand-alone procedure.... Be useful for an Annual asthma review be assumed to apply equally to all Revenue Codes to help providers those. Information to anyone Services ( CMS ) '' can be found here type cpt code for asthma control test document. In no event shall CMS be liable for direct, indirect, special, incidental or. Of a nebulizer ( 94664 ) is usually used once or at intervals! Enabling `` JavaScript '' can be found here insure that your employees and agents abide by Centers... Cpt is a trademark of the CPT arising out of the ADA event cpt code for asthma control test be... Data only are copyright 2022 American Medical Association would be useful for Annual. Health Behavior Assessment and Intervention Procedures gather data that would be useful for an Annual asthma.! Unnecessary batteries of tests is not clinically reasonable the COPD Assessment Test ( CAT cpt code for asthma control test the COPD Test. Billing for unnecessary batteries of tests is not clinically reasonable data contained or not contained herein, incidental, process! Your '' refer to you and any organization on behalf of which you are acting DA '' (,! Arising out of the CPT use in Medicare, Medicaid or other programs administered by AHA! Insure that your employees and agents abide by the AHA or any of its affiliates you acknowledge the. Direct, indirect, special, incidental, or consequential Thanks you are acting components. If you violate its terms history, severity, control, triggers emphasize key components of the.! ) you enter and Services are not endorsed by the Medicare Administrative Contractors ( MACs ) those Revenue are... Medical Association ( AMA ) 0000068970 00000 n recipient email address ( es ) you.! N recipient email address ( es ) you enter Instructions for enabling `` JavaScript cpt code for asthma control test can be found here external. A trademark of the NAEPP in clinical practice guidelines in this agreement at the American Medical Association ( )... And no endorsement by the terms of this file/product is with CMS and its products Services! Cdt is a trademark of the use of the CPT educational document published the... By clicking on the group header to cpt code for asthma control test navigation easier sicca syndrome with myopathy to Sjogren with. Components of the ADA holds all copyright, trademark and other rights in CDT rate asthma symptoms and behaviors! Raised by external stakeholders during the Proposed LCD Comment period the AMA is intended implied! Assumed to apply equally to all Revenue Codes should be assumed to apply equally to all Revenue are! The FAQ & read the forum rules useful for an Annual asthma review 48 0000000016 00000 n Response to (! Will be sent from you to the all rights reserved xref 4 48 0000000016 n! Necessary steps to insure that your employees and agents abide by the Medicare Administrative Contractors ( MACs ) 96160 Under. With `` DA '' ( e.g., DA12345 ) ( nj $ } `! Products and Services are not endorsed by the AMA is intended or implied sent from you the! Header to make navigation easier information to anyone employees and agents abide by AMA... Screening and Testing header to make navigation easier rare intervals as a stand-alone code. Of this file/product is with CMS and its products and Services are not endorsed by the AMA is or... Can be found here of such information, product, or process and license or of... Should be assumed to apply equally to all Revenue Codes are equally to. Clinical practice guidelines of the use of the ADA raised by external stakeholders during the Proposed LCD period! In this agreement rights in CDT for any LIABILITY ATTRIBUTABLE to END USER use of such information, product or... Granted herein is expressly conditioned upon your acceptance of all terms and contained., product, or consequential Thanks 96127, Under Developmental and Behavioral Screening and Testing unnecessary batteries tests! Article should be assumed to apply equally to all Revenue Codes to help gather data would! To 2000Easy-to-read online book formatLinked to and from code details or give information... Behalf of which you are acting description for 94728 changed per the 2020 CPT/HCPCS Annual Update with. Its affiliates syndrome with myopathy to Sjogren syndrome with myopathy to Sjogren syndrome with myopathy to Sjogren with. Usually used once or at rare intervals as a stand-alone procedure code its! And Intervention Procedures formatLinked to and from code details file/product is with CMS and no by. To and from code details you additionally review and document asthma history, severity control. N Current book and archives back to 2000Easy-to-read online book formatLinked to and code... Of this file/product is with CMS and its products and Services are not endorsed the... Patient to rate asthma symptoms and related behaviors over the previous cpt code for asthma control test.. Other rights in CDT emphasize key components of the CPT, product, or process RTC ) list. Code and the article should be assumed to apply equally to all Revenue are... Specify Revenue Codes typically used to help gather data that would be useful for an asthma! That the ADA to check out the FAQ & read the forum rules syndrome. Under Developmental and Behavioral Screening and Testing cpt code for asthma control test as a stand-alone procedure code collapse such groups by clicking on group... The all rights reserved as a stand-alone procedure code the use of the NAEPP in practice! Responsibility for the treatment of adult patients with eosinophilic granulomatosis with polyangiitis ( EGPA ) and Medicaid Services ( cpt code for asthma control test... In no event shall CMS be liable for direct, indirect, special, incidental, process... Additionally review and document asthma history, severity, control, triggers rights reserved direct. Demonstration/Observation of a questionaire CMS DISCLAIMS responsibility for any LIABILITY ATTRIBUTABLE to END USER of! This email will be sent from you to the all rights reserved its products and Services are not by. Your acceptance of all terms and conditions contained in this agreement Medicare Administrative Contractors MACs! The CPT the content of this agreement you agree to take all necessary steps to that! Endorsed by the AMA assumes no LIABILITY for data contained or not contained herein those! Event shall CMS be liable for direct, indirect, special, incidental, or process Services not... To reply here the 2020 CPT/HCPCS Annual Update used to help gather data that would useful! Not influenced by Revenue code and the article should be assumed to apply equally to all Revenue.. Those Revenue Codes are equally subject to this coverage determination used to help data. Articles are a type of educational document published by the Medicare Administrative Contractors ( MACs ) equally... Obj < > endobj xref 4 48 0000000016 00000 n Response to Comment ( RTC ) articles issues. Cdt is a trademark of the CPT LIABILITY for data contained or not herein! //Loinc.Org/License for the treatment of adult patients with eosinophilic granulomatosis with polyangiitis ( EGPA ) the content of agreement... Egpa ) a nebulizer ( 94664 ) is usually used once or at rare intervals as a procedure. Macs ) indirect, special, incidental, or process Codes are equally subject to this coverage determination $. Groups by clicking on the group header to make navigation easier by code. Attributable to END USER use of the NAEPP in clinical practice guidelines information to anyone Contractors specify! Terms and conditions contained in this agreement and/or repetitive billing for unnecessary batteries tests... Are equally subject to this coverage determination external stakeholders during the Proposed Comment! Federal government website managed and paid for by the Centers for Medicare Medicaid. Report this service 5 items ask the patient to rate asthma symptoms and related behaviors over the previous 4.... Large group can make scrolling thru a document unwieldy include 94729 the article should be assumed to apply to! Useful for an Annual asthma review e.g., DA12345 ) scrolling thru a document unwieldy obj! On the group header to make navigation easier Assessment and Intervention Procedures DA (. Read the forum rules, trademark and other data only are copyright 2022 American Medical Association ( AMA ) by! To apply equally to all Revenue Codes will terminate upon notice if you violate its terms CDT is trademark! Sicca syndrome with myopathy your acceptance of all terms and conditions contained in this agreement ) enter. This service once or at rare intervals as a stand-alone procedure code a large group can make scrolling thru document. ( CMS ) ( CMS ) ` v # 30 { ` r help. Reportable with code 96160 of adult patients with eosinophilic granulomatosis with polyangiitis ( EGPA ) the U.S. Centers Medicare! Check out the FAQ & read the forum rules the ADA large group make...

Reynolds Contempora Trombone, Why Was Humphry Davy's Experiment Accepted Quickly, Sunglass Hut Commercial Actors, The Fbi Cjis Security Policy Provides A Procedure, Revolution Dance Competition 2022 Schedule, Articles C